0001209191-21-042496.txt : 20210622 0001209191-21-042496.hdr.sgml : 20210622 20210622181335 ACCESSION NUMBER: 0001209191-21-042496 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210618 FILED AS OF DATE: 20210622 DATE AS OF CHANGE: 20210622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ocko Matthew CENTRAL INDEX KEY: 0001836089 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 211036583 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DCVC Bio, L.P. CENTRAL INDEX KEY: 0001735069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 211036589 BUSINESS ADDRESS: STREET 1: 317 UNIVERSITY AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 415-840-7337 MAIL ADDRESS: STREET 1: 317 UNIVERSITY AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DCVC Bio GP, LLC CENTRAL INDEX KEY: 0001735070 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 211036588 BUSINESS ADDRESS: STREET 1: 317 UNIVERSITY AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 415-840-7337 MAIL ADDRESS: STREET 1: 317 UNIVERSITY AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JNK Capital Management, LLC CENTRAL INDEX KEY: 0001836273 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 211036587 BUSINESS ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 415-840-7337 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZNM Capital Management, LLC CENTRAL INDEX KEY: 0001836103 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 211036586 BUSINESS ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 415-840-7337 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stead Kiersten CENTRAL INDEX KEY: 0001836117 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 211036584 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bogue Zachary CENTRAL INDEX KEY: 0001836157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 211036585 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbCellera Biologics Inc. CENTRAL INDEX KEY: 0001703057 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 BUSINESS PHONE: (604) 559-9005 MAIL ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-18 0 0001703057 AbCellera Biologics Inc. ABCL 0001735069 DCVC Bio, L.P. 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001735070 DCVC Bio GP, LLC 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836273 JNK Capital Management, LLC 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836103 ZNM Capital Management, LLC 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836157 Bogue Zachary 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836089 Ocko Matthew 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836117 Stead Kiersten 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 Common Shares 2021-06-18 4 J 0 5000000 0.00 D 24105761 I See Footnote Common Shares 2021-06-18 4 J 0 73892 0.00 A 73892 I See Footnote On June 18, 2021, DCVC Bio, L.P. ("DCVC Bio") distributed, for no consideration, an aggregate of 5,000,000 Common Shares of the Issuer ("DCVC Bio Shares") to its limited partners and to DCVC Bio GP, LLC ("DCVC Bio GP"), its general partner, representing each such partner's pro rata interest in such DCVC Bio Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended. These securities are held by DCVC Bio. DCVC Bio GP is the general partner of DCVC Bio and has sole voting and dispositive power with regard to the securities held by DCVC Bio. JNK Capital Management, LLC ("JNK") and ZNM Capital Management, LLC ("ZNM") are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio. (Continued from Footnote 2) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any. These securities are held by DCVC Bio GP. JNK and ZNM are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio GP. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio GP. (Continued from Footnote 4) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any. This is one of two Form 4s filed on the date hereof in respect of these securities. The Reporting Person for the other Form 4 is John Hamer. DCVC Bio, L.P. By: DCVC Bio GP, LLC Its: General Partner By: ZNM Capital Management, LLC Its: Managing Member By: /s/ Matthew Ocko Matthew Ocko, Managing Member 2021-06-21 DCVC Bio GP, LLC, By: ZNM Capital Management, LLC Its: Managing Member By: /s/ Matthew Ocko Matthew Ocko, Managing Member 2021-06-21 JNK Capital Management, LLC, By: /s/ Kiersten Stead Kiersten Stead, Managing Member 2021-06-21 ZNM Capital Management, LLC By: /s/ Matthew Ocko Matthew Ocko, Managing Member 2021-06-21 Zachary Bogue /s/ Zachary Bogue 2021-06-21 Matthew Ocko /s/ Matthew Ocko 2021-06-21 Kiersten Stead /s/ Kiersten Stead 2021-06-21